Lantmännen has signed an agreement to acquire HKScan Corporation’s Swedish operations, HKScan Sweden AB. The acquisition includes all operations in Sweden and the brands Scan, Pärsons and Bullens. The acquisition means that Lantmännen is broadening and strengthening its business portfolio from field to fork – and that long-term conditions for Swedish agriculture are strengthened.

HKScan’s Swedish operations offers meat- and plant-based food from Swedish farms, employs about 1,800 people, and in 2022 had net sales of approximately SEK 8 billion. The Swedish business has production facilities in Kristianstad, Skara, Linköping and Halmstad – and is Swedish headquarter in Stockholm.

In connection with the acquisition, Lantmännen also transfers all its existing shares in HKScan Corporation to HKScan Corporation. The transaction is subject to approval by relevant authorities, and is expected to be completed during the first half of 2024.  

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Clara Sohlberg and Robin Sultani (M&A), Johan Cederblad (Environment), Kristoffer Larson and Alexandra Tamm (Real Estate), Trine Osen Bergqvist and Jesper Ekman (Competition law), Malin Malm Waerme and Johan Gavelin (IP), Lisa Hörnqvist (GDPR), Eva Fredriksson, Jolene Reimerson and Carla Zachariasson (IT and Commercial Agreements), Mia Falk and Julia Löfquist (Regulatory), Agnes Pigg (Employment) and Emy Rydén (Transaction Support Coordinator).

Read the client's press release

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025